MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.athoracsur.2012.04.088

Медицинская библиотека · The Annals of thoracic surgery · 2012

The role of consolidation therapy for stage III non-small cell lung cancer with persistent N2 disease after induction chemotherapy.

Amini Arya, Correa Arlene M, Komaki Ritsuko, Chang Joe Y, Tsao Anne S, Roth Jack A, Swisher Stephen G, Rice David C, Vaporciyan Ara A, Lin Steven H

Сравнительное исследованиеСтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Persistent pathologic mediastinal nodal involvement after induction chemotherapy and surgical resection is a negative prognostic factor for stage III-N2 non-small cell lung cancer patients. This population has high rates of local-regional failure and distant failure, yet the effectiveness of additional therapies is not clear. We assessed the role of consolidative therapies (postoperative radiation therapy and chemotherapy) for such patients.

METHODS

In all, 179 patients with stage III-N2 non-small cell lung cancer at MD Anderson Cancer Center were treated with induction chemotherapy followed by surgery from 1998 through 2008; 61 patients in this cohort had persistent, pathologically confirmed, mediastinal nodal disease, and were treated with postoperative radiation therapy. Local-regional failure was defined as recurrence at the surgical site or lymph nodes (levels 1 to 14, including supraclavicular), or both. Overall survival was calculated using the Kaplan-Meier method, and survival outcomes were assessed by log rank tests. Univariate and multivariate Cox proportional hazards models were used to identify factors influencing local-regional failure, distant failure, and overall survival.

RESULTS

All patients received postoperative radiation therapy after surgery, but approximately 25% of the patients also received additional chemotherapy: 9 (15%) with concurrent chemotherapy, 4 (7%) received adjuvant sequential chemotherapy, and 2 (3%) received both. Multivariate analysis indicated that additional postoperative chemotherapy significantly reduced distant failure (hazard ratio 0.183, 95% confidence interval: 0.052 to 0.649, p=0.009) and improved overall survival (hazard ratio 0.233, 95% confidence interval: 0.089 to 0.612, p=0.003). However, additional postoperative chemotherapy had no affect on local-regional failure.

CONCLUSIONS

Aggressive consolidative therapies may improve outcomes for patients with persistent N2 disease after induction chemotherapy and surgery.

Для цитирования: Amini Arya, Correa Arlene M, Komaki Ritsuko, Chang Joe Y, Tsao Anne S, Roth Jack A, Swisher Stephen G, Rice David C, Vaporciyan Ara A, Lin Steven H. The role of consolidation therapy for stage III non-small cell lung cancer with persistent N2 disease after induction chemotherapy.. The Annals of thoracic surgery. 2012. DOI: 10.1016/j.athoracsur.2012.04.088.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.